Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Despite improved treatment, cardiovascular disease remains one of the most common diseases and causes of death in the Western world. Hypercholesterolemia is a well known risk factor for developing cardiovascular disease. Prevention and treatment are based in part on lowering LDL cholesterol. Dietary and lifestyle changes always play an important part of the treatment and preventive effort, and conversion to a heart-healthy diet reduces LDL cholesterol by a mean 10%. Further lowering of LDL cholesterol by means of food supplements have been demonstrated in numerous studies. Cholesterol lowering food supplements include isolated soy protein and water soluble dietary fibre such as psyllium husks. Postulated mechanisms of action responsible for the cholesterol lowering in these two food supplements are different, so there is a reason to expect an additive cholesterol lowering effect during concomitant treatment with both substances. The investigators want to investigate whether concomitant treatment with psyllium husks and isolated soy protein in addition to a heart-healthy diet results in a significantly greater reduction of LDL cholesterol in hypercholesterolemia, than single treatment with each of the substances.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Combinatorial treatment | Experimental |
| |
| Single treatment: Psyllium husks | Active Comparator |
| |
| Single treatment: Isolated soy protein | Active Comparator |
| |
| Control | Placebo Comparator |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Psyllium husks | Drug | Oral suspension, oral use, two daily dosages consisting of 5 grams each |
|
| Measure | Description | Time Frame |
|---|---|---|
| Change from baseline in LDL cholesterol at 6 weeks | 3rd and 4th visits equal the ends of the 1st and 2nd intervention period at +6 weeks and +16 weeks from baseline respectively (4 week wash-out period in between the intervention periods). 2nd visit includes randomization and baseline measurement, while 1st visit @ -4 weeks compared to baseline includes screening and inclusion | 3rd and 4th visits at the investigational site |
| Measure | Description | Time Frame |
|---|---|---|
| Change from baseline in total cholesterol at 6 weeks | 3rd and 4th visits at the investigational site | |
| Change from baseline in HDL cholesterol at 6 weeks | 3rd and 4th visits at the investigational site |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Erik B. Schmidt, Professor, MD | Lipidklinikken, Aalborg Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| The Lipid Clinic, Aalborg Hospital | Aalborg | RN | 9000 | Denmark |
Not provided
| ID | Term |
|---|---|
| D006937 | Hypercholesterolemia |
| ID | Term |
|---|---|
| D006949 | Hyperlipidemias |
| D050171 | Dyslipidemias |
| D052439 | Lipid Metabolism Disorders |
| D008659 | Metabolic Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D030262 | Soybean Proteins |
| C109691 | microcrystalline cellulose |
| ID | Term |
|---|---|
| D010940 | Plant Proteins |
| D011506 | Proteins |
| D000602 | Amino Acids, Peptides, and Proteins |
| D014674 | Plant Proteins, Dietary |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Isolated soy protein | Dietary Supplement | Oral suspension, oral use, 30 grams once per day |
|
| Isolated whey protein | Dietary Supplement | Oral suspension, oral use, 30 grams once per day |
|
| Microcrystalline cellulose | Other | Oral suspension, oral use, two daily dosages consisting of 5 grams each |
|
| Change from baseline in triglycerides at 6 weeks | 3rd and 4th visits at the investigational site |
| Change from baseline in fasting plasma glucose at 6 weeks | 3rd and 4th visits at the investigational site |
| Change from baseline in body weight at 6 weeks | 3rd and 4th visits at the investigational site |
| Change from baseline in apolipoprotein B at 6 weeks | 3rd and 4th visits at the investigational site |
| Change from baseline in small, dense LDL cholesterol at 6 weeks | 3rd and 4th visits at the investigational site |
| Change from baseline in high sensitive CRP at 6 weeks | 3rd and 4th visits at the investigational site |
| D009750 |
| Nutritional and Metabolic Diseases |
| D004044 |
| Dietary Proteins |
| D005502 | Food |
| D000066888 | Diet, Food, and Nutrition |
| D010829 | Physiological Phenomena |
| D045730 | Soy Foods |
| D000067075 | Vegetable Products |
| D014675 | Vegetables |
| D019602 | Food and Beverages |